Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation
Hirotaka Hoshi(Fukushima Medical University), Motoki Takagi(Fukushima Medical University), Kentaro Semba(Fukushima Medical University), Arisa Higa(Université de Bordeaux), Gen Hiyama(Fukushima Medical University), Yoshifumi Kawamura(Tohoku University), Ai Wakamatsu(Kazusa DNA Research Institute), Shinya Watanabe(Fukushima Medical University), Nobuhiko Takahashi(Health Sciences University of Hokkaido), Kiyoshi Inageda(Fukushima Medical University), Kosuke Ishikawa(Waseda University), Takushi Togashi(Japan Biological Informatics Consortium), Naoki Goshima(National Institute of Advanced Industrial Science and Technology), Jiro Fujimoto(Harvard University)
Cited by 18
Related Papers
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes
|Genome Research|2005|506